Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
for Acute Myeloid Leukemia, in Relapse
Sites in Winston-Salem, Charlotte +1 more location
Sponsor: ARCE Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06680752·Phase 1, Phase 2·Recruiting·Listed Nov 2024